SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Somatogen (SMTG)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RCMac who wrote (337)12/5/1997 8:32:00 PM
From: Bharat H. Barai  Read Replies (1) of 442
 
Biopure's Animal Hemoglobin derived substitute is an interesting concept. My feeling is that their vet product may sell well. I doubt any human being will want to get infused with bovine hemoglobin based product if another genetically engineered product is available.

In the field of vaccines, factor 8 concentrates, diagnostic thromboplastin etc., once genetically engineered products have become available; human or animal based products have rapidly lost market share. For Hemoglobin substitute, it will happen within no time.

I still believe that in the spectrum of products being tested, Somatogen has the most suitable product. Alliance Pharma's Perflubro based compounds come next. Human Hemoglobin based substitutes come third. Animal based Hb substitutes will have very hard time competing in such a scenario.

Bharat H. Barai MD

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News